Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Single-balloon enteroscopic retrograde cholangiopancreatography in the setting of altered upper gastrointestinal anatomy.

Smith S, Stagg J, Naumann C.

Proc (Bayl Univ Med Cent). 2018 Oct 26;31(4):467-469. doi: 10.1080/08998280.2018.1499315. eCollection 2018 Oct.

2.

Validated automatic speech biomarkers in primary progressive aphasia.

Nevler N, Ash S, Irwin DJ, Liberman M, Grossman M.

Ann Clin Transl Neurol. 2018 Nov 24;6(1):4-14. doi: 10.1002/acn3.653. eCollection 2019 Jan.

3.

Combining high wavenumber and fingerprint Raman spectroscopy for the detection of prostate cancer during radical prostatectomy.

Aubertin K, Desroches J, Jermyn M, Trinh VQ, Saad F, Trudel D, Leblond F.

Biomed Opt Express. 2018 Aug 15;9(9):4294-4305. doi: 10.1364/BOE.9.004294. eCollection 2018 Sep 1.

4.

Multiple remissions of extracavitary primary effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV.

Chen J, Mehraj V, Szabo J, Routy B, Michel RP, Routy JP.

Curr Oncol. 2018 Dec;25(6):e592-e596. doi: 10.3747/co.25.4119. Epub 2018 Dec 1.

5.

Association between audiometric patterns and probabilities of cardiovascular diseases.

Bertrand RA, Huang Z.

Laryngoscope Investig Otolaryngol. 2018 Oct 30;3(6):478-485. doi: 10.1002/lio2.206. eCollection 2018 Dec.

6.

Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study.

Preisser F, Mazzone E, Nazzani S, Knipper S, Tian Z, Mandel P, Pompe R, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2018 Dec 26. pii: S2405-4569(18)30405-X. doi: 10.1016/j.euf.2018.12.006. [Epub ahead of print]

PMID:
30594487
7.

Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.

Nazzani S, Mazzone E, Preisser F, Tian Z, Mistretta FA, Shariat SF, Montanari E, Acquati P, Briganti A, Saad F, Carmignani L, Karakiewicz PI.

Eur J Surg Oncol. 2018 Dec 11. pii: S0748-7983(18)32026-2. doi: 10.1016/j.ejso.2018.12.004. [Epub ahead of print]

PMID:
30563773
8.

Integrating Voice Quality Cues in the Pitch Perception of Speech and Non-speech Utterances.

Kuang J, Liberman M.

Front Psychol. 2018 Nov 29;9:2147. doi: 10.3389/fpsyg.2018.02147. eCollection 2018.

9.

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

Johnston S, Puhalla S, Wheatley D, Ring A, Barry P, Holcombe C, Boileau JF, Provencher L, Robidoux A, Rimawi M, McIntosh SA, Shalaby I, Stein RC, Thirlwell M, Dolling D, Morden J, Snowdon C, Perry S, Cornman C, Batten LM, Jeffs LK, Dodson A, Martins V, Modi A, Osborne CK, Pogue-Geile KL, Cheang MCU, Wolmark N, Julian TB, Fisher K, MacKenzie M, Wilcox M, Huang Bartlett C, Koehler M, Dowsett M, Bliss JM, Jacobs SA.

J Clin Oncol. 2019 Jan 20;37(3):178-189. doi: 10.1200/JCO.18.01624. Epub 2018 Dec 6.

PMID:
30523750
10.

Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.

Collin Y, Paré A, Belblidia A, Létourneau R, Plasse M, Dagenais M, Turcotte S, Martel G, Roy A, Lapointe R, Vandenbroucke-Menu F.

Int J Surg. 2019 Jan;61:42-47. doi: 10.1016/j.ijsu.2018.11.029. Epub 2018 Dec 8.

PMID:
30537548
11.

Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?

Mazzone E, Knipper S, Mistretta FA, Tian Z, Preisser F, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.

Cancer Epidemiol. 2019 Feb;58:83-88. doi: 10.1016/j.canep.2018.11.007. Epub 2018 Dec 6.

PMID:
30528834
12.

More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.

Mazzone E, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Apr;17(2):105-113.e2. doi: 10.1016/j.clgc.2018.11.003. Epub 2018 Nov 17.

PMID:
30527745
13.

Impact of adipose tissue on prostate cancer aggressiveness - analysis of a high-risk population.

Delouya G, Tiberi D, Bhatnagar SR, Campeau S, Saad F, Taussky D.

Horm Mol Biol Clin Investig. 2018 Nov 24;36(3). pii: /j/hmbci.2018.36.issue-3/hmbci-2018-0049/hmbci-2018-0049.xml. doi: 10.1515/hmbci-2018-0049.

PMID:
30471220
14.

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman LJ.

Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.

PMID:
30442588
15.

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.

Preisser F, Mazzone E, Nazzani S, Marchioni M, Bandini M, Tian Z, Saad F, Soulières D, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Br J Cancer. 2018 Dec;119(12):1552-1556. doi: 10.1038/s41416-018-0323-3. Epub 2018 Nov 14.

PMID:
30425350
16.

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.

Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB; Cancer Genome Atlas Research Network, Camargo F, Liang H.

Cell Rep. 2018 Oct 30;25(5):1304-1317.e5. doi: 10.1016/j.celrep.2018.10.001.

17.

Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer.

Preisser F, Mazzone E, Knipper S, Nazzani S, Bandini M, Shariat SF, Tian Z, Saad F, Montorsi F, Zorn KC, Graefen M, Tilki D, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Feb;17(1):e130-e139. doi: 10.1016/j.clgc.2018.09.024. Epub 2018 Oct 4.

PMID:
30366880
18.

Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.

Bandini M, Nazzani S, Marchioni M, Preisser F, Tian Z, Moschini M, Abdollah F, Suardi N, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Feb;17(1):72-78.e4. doi: 10.1016/j.clgc.2018.09.011. Epub 2018 Sep 22.

PMID:
30342845
19.

The intimate relationship between gut microbiota and cancer immunotherapy.

Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B.

Gut Microbes. 2018 Oct 19:1-5. doi: 10.1080/19490976.2018.1527167. [Epub ahead of print]

PMID:
30339501
20.

Tout le poids d'un nom, ou faut-il renommer notre spécialité?

Saad F.

Can Urol Assoc J. 2018 Oct;12(10):E428. doi: 10.5489/cuaj.5657. No abstract available.

Supplemental Content

Loading ...
Support Center